Robert A. Harrington, MD

Opinion

Cardiovascular Disease 2050: No, GLP-1s Won’t Save the Day

Author:: Robert A. Harrington, MD

Publish date: October 28, 2024

Harvard Medical School professor tells “where we will be in 2050” if prior trends remain the same.

News

Private Equity in Medicine: Cardiology in the Crosshairs

Author:: Robert A. Harrington, MD

Publish date: August 20, 2024

Private equity firms’ goal is to turn a profit for institutional investors over a 3- to 7-year time horizon.

Opinion

SCD in athletes: Lessons from high-profile cases

Author:: Robert A. Harrington, MD

Publish date: September 19, 2023

There are certainly things that we know we should be intervening on and others where participation is a question. All of these we are trying to lon...